Loading...
Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington’s Disease Pre-clinical Model
Although several agents have been identified to provide therapeutic benefits in Huntington disease (HD), the number of conventionally used treatments remains limited and only symptomatic. Thus, it is plausible that the need to identify new therapeutic targets for the development of alternative and m...
Na minha lista:
| Udgivet i: | Front Mol Neurosci |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491579/ https://ncbi.nlm.nih.gov/pubmed/31068790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2019.00100 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|